ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
11 announcements
Godavari Biorefineries received a Rs. 12.88 Crore demand notice from HESCOM for cross-subsidy charges on power imported between 2013-2016. The company is assessing the liability.
China's patent office granted Godavari Biorefineries a patent for compounds treating viral infections. The invention covers V-ATPase inhibition for medicament use.
Godavari Biorefineries Ltd has been granted a patent by the European Patent Office for its 'A Biofiller for Rubber Reinforcement' technology.
Godavari Biorefineries Limited submitted its 2025-26 Annual Report, prior to the 71st Annual General Meeting scheduled for September 28, 2026.
Godavari Biorefineries Ltd issued the notice for its 71st Annual General Meeting, scheduled for September 28, 2026, via video conferencing.
Q1 FY27 revenue grew 4.6% to ₹557.9 Cr, but EBITDA fell to ₹2.6 Cr. Performance was pressured by high inventory costs and raw material prices despite strong chemical segment growth.
Godavari Biorefineries reported Q1 FY27 total income of ₹559.9 Cr, up 4.9% YoY. Strategy focuses on bio-based chemicals and ethanol capacity expansion.
Godavari Biorefineries Ltd reported revenue from operations of ₹557.9 Cr (+4.6% YoY) and a net loss of ₹19.3 Cr for Q1 FY27.
Godavari Biorefineries delivered a turnaround in FY26, reporting ₹2,000 cr total income and a positive PAT of ₹3.5 cr, driven by operational efficiencies and debt reduction.
Godavari Biorefineries reported FY26 total income of ₹2,000.2 Cr, up 6% YoY, with EBITDA margins stabilizing at 7% as the company shifts towards high-margin bio-based specialty chemicals.
Godavari Biorefineries Ltd reported revenue from operations of ₹564.1 Cr (-2.7% YoY) and net profit of ₹52.9 Cr (-26.4% YoY) for Q4 FY26.